...
首页> 外文期刊>Liver international : >Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma
【24h】

Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma

机译:肝细胞癌中SWI / SNF染色质重塑亚基BRG1和BRM的变化

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background: The SWI/SNF chromatin remodelling complex, which contains either brahma-related gene-1 (BRG1) or brahma (BRM) as the catalytic ATPase, functions as a master regulator of gene expression. Aims: To examine alterations of BRG1 and BRM in hepatocellular carcinoma (HCC). Methods: We investigated DNA copy number aberrations in human HCC cell lines using a high-density oligonucleotide microarray. We determined DNA copy numbers and expression levels of BRG1 and BRM genes in primary HCC tumours, and conducted further searches for mutations in BRG1 and BRM genes. Results: Homozygous deletion of the BRG1 gene was found in HCC cell line SNU398. Copy number losses of BRG1 and BRM genes were observed in 14 (26%) and 7 (13%) of 54 primary HCC tumours respectively. We found four somatic missense mutations in the BRG1 gene in two of 36 primary HCC tumours, but no mutations in BRM gene. Expression of BRM mRNA, but not BRG1 mRNA, was significantly reduced in primary HCC tumours, compared to non-tumour tissue counterparts. Immunohistochemical analyses of non-tumour liver tissues showed that BRM protein was expressed in hepatocytes and bile-duct epithelial cells, whereas BRG1 protein was expressed in bile-duct epithelial cells, but not in hepatocytes. BRM protein expression was lost in nine (22.5%) of 40 HCC tumours. Loss of BRM protein expression was significantly associated with poor overall survival. Conclusion: Reduced expression of BRM may contribute to the carcinogenesis of HCC. Although deletions and mutations in BRG1 gene were identified, the role of BRG1 in HCC tumourigenesis remains unclear.
机译:背景:SWI / SNF染色质重塑复合物,包含婆罗门相关基因1(BRG1)或婆罗门(BRM)作为催化ATPase,是基因表达的主要调控因子。目的:研究肝细胞癌(HCC)中BRG1和BRM的改变。方法:我们使用高密度寡核苷酸微阵列研究了人类HCC细胞系中的DNA拷贝数畸变。我们确定了原发性HCC肿瘤中DNA的拷贝数和BRG1和BRM基因的表达水平,并进一步搜索了BRG1和BRM基因的突变。结果:在HCC细胞系SNU398中发现了BRG1基因的纯合缺失。在54例原发性HCC肿瘤中,分别有14例(26%)和7例(13%)观察到BRG1和BRM基因的拷贝数丢失。我们在36个原发性HCC肿瘤中的两个中发现了BRG1基因中的四个体细胞错义突变,但BRM基因中没有突变。与非肿瘤组织对应物相比,在原发性肝癌中,BRM mRNA的表达而非BRG1 mRNA的表达显着降低。对非肿瘤肝组织的免疫组织化学分析表明,BRM蛋白在肝细胞和胆管上皮细胞中表达,而BRG1蛋白在胆管上皮细胞中表达,但在肝细胞中不表达。 BRM蛋白表达在40例HCC肿瘤中有9例(22.5%)丢失。 BRM蛋白表达的丧失与总体生存率低显着相关。结论:BRM表达降低可能与肝癌的发生有关。尽管已鉴定出BRG1基因的缺失和突变,但仍不清楚BRG1在HCC肿瘤发生中的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号